Anxiogenic-like effects of a root extract of Sphenocentrum jollyanum pierre in murine behavioural models

Journal of Pharmacology and Toxicology

Volumn 4, Issue 3, 2009, Pages 91-106

  Woode, Eric ^a   Amidu, N ^a   Owiredu, William K B A ^a   Boakye Gyasi, E ^a   Laing, E F ^a   Ansah, C ^a   Duwiejua, M ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Anxiety; Caffeine; Diazepam; Elevated plus maze; Hole board; Light dark box; Open field

Indexed keywords

ALKALOID DERIVATIVE; CAFFEINE; DIAZEPAM; FLAVONOID; PLANT EXTRACT; SPHENOCENTRUM JOLLYANUM EXTRACT; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DISEASE MODEL; DRUG SCREENING; LIGHT DARK CYCLE; MAZE TEST; MENISPERMACEAE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OPEN FIELD TEST; PLANT ROOT; QUALITATIVE ANALYSIS; ROTAROD TEST; SPHENOCENTRUM JOLLYANUM; TRANQUILIZING ACTIVITY;

EID: 68049094823     PISSN: 1816496X     EISSN: None     Source Type: Journal    
DOI: 10.3923/jpt.2009.91.106     Document Type: Article

References (50)

1. Abbiw, D.K., 1990. Useful Plants of Ghana. 1st Edn., Intermediate Technology Publications and Royal Botanic Gardens Kew, London, ISBN: 1-85339-043-7.
2. Asano, Y., 1986. Characteristics of open-field behavior of Wistar and Sprague Dawley rats. Jikken Dobutau, 35: 505-508.
3. Belzung, C., R. Misslin, E. Vogel, R.H. Dodd and G. Chapouthier, 1987. Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/ dark choice situation. Pharmacol. Biochem. Behav., 28: 29-33.
4. Belzung, C. and G. Le Pape, 1994. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav., 56: 623-628.
5. Bhattacharya, S.K., K.S. Satyan and A. Chakrabarti, 1997. Anxiogenic action of caffeine: An experimental study in rats. J., Psychopharmacol., 11: 219-224.
6. Boissier, J.R., P. Simon and J.M. Lwoff, 1964. Use of a particular mouse reaction (Hole Board Method) for the study of psychotropic drugs. Therapie, 19: 571-583.
7. Borsini, F., J. Podhorna and D. Marazziti, 2002. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology, 163: 121-141.
8. Burkill, H.M., 1985. The Useful Plants of West Africa. 2nd Edn., The Royal Botanical Gargens, Ithaka Harbors Incorporation, Kew, UK., ISBN-10: 094764301X.
9. Chaouloff, F., M. Durand and P. Mormede, 1997. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav. Brain Res., 85: 27-35.
10. Choleris, E., A.W. Thomas, M. Kavaliers and F. S. Prato, 2001. A detailed ethological analysis of the mouse open field test: Effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev., 25: 235-260.
11. Costall, B., B.J. Jones, M.E. Kelly, R.J. Naylor, N.R. Oakley, E.S. Onaivi and M.B. Tyers, 1989. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behav., 34: 769-778.
12. Crawley, J.N., 1981. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazopines. Pharmacol. Biochem. Behav., 15: 695-699.
13. Crawley, J.N., J.K. Belknap, A. Collins, J.C. Crabbe, W. Frankel and N. Henderson et. al., 1997. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies. Psychopharmacology, 132: 107-124.
14. Crawley, J.N., 1999. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities and specific behavioral tests. Brain Res., 835: 18-26.
15. Cruz, A.P.M., F. Frei and F.G. Graeff, 1994. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav., 49: 171-176.
16. Du, J. and E.M. Hull, 1999 Effects of testosterone on neuronal nitric oxide synthase and tyrosine hydroxylase. Brain Res., 836: 90-98.
17. El Yacoubi, M., C. Ledent, M. Parmentier, J. Costentin and J.M. Vaugeois, 2000. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A (2A) adenosine receptor antagonists. Psychopharmacology, 148: 153-163.
18. Erdogan, F., A. Golgeli, F. Arman and A.O. Ersoy, 2004. The effects of pentylenetetrazole-induced status epilepticus on behavior, emotional memory and learning in rats. Epilepsy Behav., 5: 388-393.
19. File, S. and A.G. Wardill, 1975. Validity of head-dipping as a measure of explorating a modified hole-board. Psychopharmacology, 44: 53-59.
20. File, S.E., S. Pellow and L.H. Jensen, 1986. Actions of the beta-carboline ZK 93426 in an animal test of anxiety and the holeboard: Interactions with Ro 15-1788. J. Neural Transm., 65: 103-114.
21. Gordon, J.A. and R. Hen, 2004. Genetic approaches to the study of anxiety. Annu. Rev. Neurosci., 27: 193-222.
22. Griebel, G., G. Perrault and D.J. Sanger, 1997. CCK receptor antagonists in animal models of anxiety: Comparison between exploration tests, conflict procedures and a model based on defensive behaviours. Behav. Pharmacol., 8: 549-560.
23. Handley, S.L. and S. Mithani. 1984. Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model for fear-motivated behavior. Namyn Schmiedebergs Arch. Pharmacol., 327: 1-5.
24. Hull, E.M., D.S. Lorrain, J. Du, L. Matuszewich, L.A. Lumley, S.K. Putnam and J. Moses, 1999. Hormme-neurotransmitter interactions in the control of sexual behavior. Behav. Brain. Res., 105: 105-116.
25. Hull, E.M. and J.M. Dominguez, 2007. Sexual behavior in male rodents. Horm. Behav., 52: 45-55.
26. Irvine, F.R., 1961. Woody Plants of Ghana with Special Reference to Their Uses. Oxford University Press, Lohdon.
27. Iwu, M., 1993. Handbook of African Medicinal Plants. 1st Edn., CRC Press Inc., Florida, ISBN: 0-84934.-266-X pp: 239.
28. Kasture, V.S., V.K. Deshmukh and C.T. Chopde, 2002. Anxiolytic and anticonvulsive activity of Sesbania grandiflora leaves in experimental animals. Phytother. Res., 16: 455-460.
29. Kliethermes, C.L., 2005. Anxiety-like behaviors following chronic ethanol exposure. Neurosci. Biobehav. Rev., 29: 837-850.
30. Lister, R., 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92: 180-185.
31. Mechan, A.O., P.M. Moran, M. Elliott, A.J. Young, M.H. Joseph and R. Green, 2002. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters and their response to diazepam. Psychopharmacology, 159: 188-195.
32. Moody, J.O., V.A. Robert, J.D. Connolly and P.J. Houghton, 2006. Anti-inflammatory activities of the methanol extracts and an isolated furanoditerpene constituent of Sphenocentrum jollyanum pierre (Menispermaceae). J. Ethnopharmacol., 104: 87-91.
33. Nia, R., D.H. Paper, E.E. Essien, K.C. Iyadi, A.I.L. Bassey and A.B. Antai et al., 2004. Evaluation of the anti-oxidant and anti-angiogemc effects of Sphenocentrum jollyanum pierre. Afr. J. Biomed. Res., 7: 129-132.
34. Ohl, F., 2005. Animal Models of Anxiety. In: Handbook of Experimental Pharmacology, Holsboer, F. and A. Ströhle (Eds.) Springer-Verlag, New York, pp: 35-69.
35. Owiredu, W.K.B.A., A. Nafiu, F. Ammisah and E. Woode, 2007. The effects of Sphenocentrum jollyanum pierre root extract on sexual behaviour and hormonal levels in rodents. J. Sci. Technol., 27: 9-21.
36. Pellow, S., P. Chopin, S.E. File and M. Briley, 1985. Validation of open: Closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J. Neurosci. Methods, 14: 149-167.
37. Pellow, S. and S.E. File, 1986. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav., 24: 525-529.
38. Phillips, K.M., 1982. Effects of time and administration of ethanol on open field behavior in hamsters. Physiol, Behav., 29: 785-787.
39. Prut L. and C. Belzung, 2003. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. Eur. J. Pharmacol., 463: 3-33.
40. Raji, Y., O.O. Fadare, R.A. Adisa and S.A. Salami, 2006. Comprehensive assessment of the effect of Sphenocentrum jollyanum root extract on male reproductive activity in albino rats. Reprod. Med. Biol., 5: 283-292.
41. Ribeiro, R.L. and T.C. De Lima, 2002. Participation of GABAA receptors in the modulation of experimental anxiety by tachykinin agonists and antagonists in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 26: 861-869.
42. Rodgers, R.J. and N.J. Johnson, 1995: Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav., 52: 297-303.
43. Rodgers, R.J., B.J. Cao, A. Dalvi and A. Holmes, 1997. Animal models of anxiety: An ethological perspective. Braz. J. Med. Biol. Res., 30: 289-304.
44. Takeda, H., M. Tsuji and T. Matsumiya, 1998. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol., 350: 21-29.
45. Trease, G.E. and W.C. Evans, 1989. A Textbook of Pharmacognosy. 13th Edn., Bailliere Tindall Ltd., London, ISBN: 0 7020 1361 7.
46. Trullas, R. and P. Skolnick, 1993. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology, 3: 323-331.
47. Van Gaalen, M.M. and T. Steckler, 2000. Behavioural analysis of four mouse strain in an anxiety test battery. Behav. Brain Res., 115: 95-106.
48. Weiss, S.M., G. Wadsworth, A. Fletcher and C.T. Dourish, 1998. Utility of ethological analysis to overcome locomotor confounds in the elevated maze models of anxiety. Neurosci. Biobehav. Rev., 23: 265-271.
49. Wolfman, C., H. Viola, A. Paladini, F. Dajas and J.H. Medina, 1994. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. Behav., 47: 1-4.
50. Yasumatsu, H., Y. Morimoto, Y. Yamamoto, S. Takehara, T. Fukuda, T. Nakao and M. Setoguchi, 1994. The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist. Br. J. Pharmacol., 111: 1170-1178.